Atlas Trials

Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®

Clinical trial NCT02730871 · TERMINATED

Trial details

NCT number
NCT02730871
Sponsor
Alcon Research
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Open-angle GlaucomaOcular Hypertension
Start date
2016-06-24
Primary completion
2018-07-13
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.